WILMAN NAVARRETO: Open Payments
NPI 1801231253 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 9 payments from 1 company in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $197 |
Products named: INGREZZA.
Industry payments across NY — which companies pay providers there.
